Recently, a paradigm in which CRS has been differentiated into CRS endotypes based on prominent inflammatory cells, such as eosinophils, or specific cytokines, such as IL-4, IL-5, and IL-13 [14]. The gene discussed is IL13; the disease is congenital rubella syndrome.